Warning: This security is no longer trading.
Novartis successfully completes acquisition of Endocyte
Endocyte, Inc. (ECYT): Price and Financial Metrics
ECYT Price/Volume Stats
| Current price | $23.99 | 52-week high | $24.00 |
| Prev. close | $24.00 | 52-week low | $2.81 |
| Day low | $23.99 | Volume | 2,340,200 |
| Day high | $24.00 | Avg. volume | 1,985,622 |
| 50-day MA | $22.67 | Dividend yield | N/A |
| 200-day MA | $16.22 | Market Cap | 1.97B |
ECYT Stock Price Chart Interactive Chart >
Endocyte, Inc. (ECYT) Company Bio
Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company was founded in 1995 and is based in West Lafayette, Indiana.
ECYT Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...